Scientists at Barts Cancer Institute at Queen Mary, University of London and The University of Nottingham have uncovered a previously unknown level of hypoxic regulation at a molecular level in human cells, which could provide a novel pathway for the development of new drug therapeutics to fight disease.
The cutting-edge work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC).
The finding has been published in the international journal Nature Cell Biology.
Source: ANI
